FAScinate Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Investors
-
3
FAScinate Therapeutics General Information
Description
Developer of novel drugs and therapeutics designed to treat Parkinson's disease. The company develops drugs for neurodegenerative diseases such as multiple system atrophy, enabling the healthcare industry to help patients modify the disease course and improve patients' overall quality of life.
Contact Information
Website
www.fascinatetherapeutics.comCorporate Office
- 4365 Executive Drive
- Suite 660
- San Diego, CA 92121
- United States
Corporate Office
- 4365 Executive Drive
- Suite 660
- San Diego, CA 92121
- United States
FAScinate Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | Cancelled | Clinical Trials - Phase 2 | ||||
| 2. Early Stage VC (Series A) | 01-Aug-2020 | Completed | Clinical Trials - Phase 2 | |||
| 1. Accelerator/Incubator | Completed | Clinical Trials - Phase 2 |
FAScinate Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
FAScinate Therapeutics Signals
FAScinate Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kainos Medicine | Corporation | Minority | ||
| Wells Investment | Growth/Expansion | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator |
FAScinate Therapeutics Investments (1)
FAScinate Therapeutics’s most recent deal was a Seed Round with Egret Therapeutics. The deal was made on 15-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Egret Therapeutics | 15-Feb-2022 | Seed Round | Biotechnology |
FAScinate Therapeutics FAQs
-
When was FAScinate Therapeutics founded?
FAScinate Therapeutics was founded in 2018.
-
Where is FAScinate Therapeutics headquartered?
FAScinate Therapeutics is headquartered in San Diego, CA.
-
What is the size of FAScinate Therapeutics?
FAScinate Therapeutics has 3 total employees.
-
What industry is FAScinate Therapeutics in?
FAScinate Therapeutics’s primary industry is Drug Discovery.
-
Is FAScinate Therapeutics a private or public company?
FAScinate Therapeutics is a Private company.
-
What is FAScinate Therapeutics’s current revenue?
The current revenue for FAScinate Therapeutics is .
-
How much funding has FAScinate Therapeutics raised over time?
FAScinate Therapeutics has raised $15M.
-
Who are FAScinate Therapeutics’s investors?
Kainos Medicine, Wells Investment, and CONNECT (San Diego) have invested in FAScinate Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process